Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical treatments, today announced $30 million in debt financing from K2 HealthVentures (K2HV), a healthcare-focused specialty finance company, to accelerate commercialization of its leading smoking cessation solution, Clickotine™, and to advance its pipeline of clinically-validated digital therapeutics [Read more…] about Click Therapeutics raises $30 million in debt to advance commercialization of smoking cessation app Clickotine
To understand the brain you need electronic engineers too (The Conversation):
“Electronic engineers are emerging as important contributors to understanding of the workings of the human brain.
There is a rapidly growing intersection between electronic engineering and neuroscience. [Read more…] about On the convergence of neuroscience and electronic engineering